Press / Publications

In his work in the field of reactive intermediates, Lars Gössl focuses on quantity-optimized and demand-driven production of various organozinc halides as well as their conversion into synthetically relevant compounds.

Ammonia has been traditionally known for fertilizer production. In the future, it could also play a key role in the Energy Transition as an efficient source of hydrogen and a climate-friendly substitute for fossil fuels since it can be produced from nitrogen and hydrogen with zero carbon emissions. Furthermore, ammonia offers a wealth of advantages in terms of transportation and storage. The Fraunhofer Institute for Microengineering and Microsystems IMM is working on a space-saving, efficient and, above all, decentralized ammonia cracking technology in numerous research projects.

Fraunhofer IMM, part of the globally renowned Fraunhofer-Gesellschaft, today announced the signing of a Memorandum of Understanding (MoU) with CATUG, Basel, Switzerland. This strategic collaboration will drive joint research and development initiatives, particularly in the fields of nucleic acids and nanoparticle technology. CATUG is a pioneering contract service provider in RNA therapeutics and LNP formulations. The collaboration between Fraunhofer IMM and CATUG will leverage their combined expertise in sustainable technologies, scalable nanoformulation systems, and advanced nanoanalytics. Together, the partnership aims to accelerate innovation in therapeutic solutions, particularly in RNA and lipid nanoparticle (LNP) formulations.

Dr. Johannes Rocker received the a Poster Award at IMRET 2024 in Graz, Austria. His poster, entitled “Electron-mediated Biocatalyzed Synthesis of Chiral Fine Chemicals in Microstructured Flow Reactors,” presents innovative approaches to the electrification of organic syntheses by combining biocatalysis and electrochemistry.

Bright prospects for personalized medicine: Experts from the Fraunhofer Institute for Microengineering and Microsystems IMM harness their know-how in microfluidics and single-cell technologies to print organ structures. They will be presenting their developments at the joint Fraunhofer booth (Hall 3, Booth E74) at the MEDICA 2024 trade show from November 11 to 14.

Parker Hannifin and the Fraunhofer Institute for Microengineering and Microsystems (IMM) today announced the renewal of their partnership to further develop air adsorption technology for fuel cell humidification applications. Gregory Brickett, General Manager, Engine Mobile Filtration Europe (EMFE) Division, said: “This collaboration builds on the successful partnership which started in October 2022, and which led to significant advancements in fuel cell technology, including the development of a specialized test rig.”

We congratulate Eva Deitmann on the successful defense of her Doctoral thesis. Deitmann's thesis deals with the continuous, scalable formation of Grignard reagents.

Transport and trade on the ocean blue must be made much greener. This is the goal of the new €17 million European GAMMA project, where companies and researchers from Europe will develop and convert a bulk carrier to sail on climate-neutral fuels and green power.

mRNA-based vaccines and gene/cell therapeutics open up new possibilities for medical practitioners in the fight against cancer and infectious or hereditary diseases. However, manufacturing these innovative pharmaceuticals is an expensive and time-consuming process. The Fraunhofer RNAuto lighthouse project is aiming to use automated production technologies to facilitate cost-effective, high-volume production of mRNA-based drugs and medicines for personalized therapies which can then be made available at an affordable price. From November 13 to 16, researchers from the Fraunhofer-Gesellschaft will, for the first time, present a screening system demonstrator for the automated encapsulation of mRNA in nanotransporters at COMPAMED in Düsseldorf (Hall 8a, Booth G10).